RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/12422060http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/12422060http://www.w3.org/2000/01/rdf-schema#comment"Genetic polymorphism of the serotonin 5-HT(2A) receptor seems to be associated with therapeutic response to selective serotonin reuptake inhibitors (SSRIs). The present study investigated whether a novel -1438G/A polymorphism in the promoter region of the 5-HT(2A )receptor gene is associated with therapeutic response to fluvoxamine (an SSRI) in 66 Japanese patients with major depressive disorder. Fluvoxamine (50 to 200 mg) was administered twice daily for 6 weeks. Fifty-four patients completed this study. The genotype distribution and the allele frequencies showed no significant difference between responders and non-responders. The time-course of the Montgomery-Asberg Depression Rating Scale scores showed no significant difference among -1438G/G, -1438G/A, and -1438A/A genotype groups. The results demonstrated that the -1438G/A promoter polymorphism in the 5-HT(2A) receptor gene was unlikely to have a major role in therapeutic response to fluvoxamine in Japanese patients with major depressive disorder."xsd:string
http://purl.uniprot.org/citations/12422060http://purl.org/dc/terms/identifier"doi:10.1159/000066394"xsd:string
http://purl.uniprot.org/citations/12422060http://purl.uniprot.org/core/author"Inoue K."xsd:string
http://purl.uniprot.org/citations/12422060http://purl.uniprot.org/core/author"Itoh K."xsd:string
http://purl.uniprot.org/citations/12422060http://purl.uniprot.org/core/author"Ito K."xsd:string
http://purl.uniprot.org/citations/12422060http://purl.uniprot.org/core/author"Suzuki T."xsd:string
http://purl.uniprot.org/citations/12422060http://purl.uniprot.org/core/author"Sato K."xsd:string
http://purl.uniprot.org/citations/12422060http://purl.uniprot.org/core/author"Shimizu T."xsd:string
http://purl.uniprot.org/citations/12422060http://purl.uniprot.org/core/author"Takahashi H."xsd:string
http://purl.uniprot.org/citations/12422060http://purl.uniprot.org/core/author"Sugawara K."xsd:string
http://purl.uniprot.org/citations/12422060http://purl.uniprot.org/core/author"Yoshida K."xsd:string
http://purl.uniprot.org/citations/12422060http://purl.uniprot.org/core/author"Kamata M."xsd:string
http://purl.uniprot.org/citations/12422060http://purl.uniprot.org/core/author"Ohkubo T."xsd:string
http://purl.uniprot.org/citations/12422060http://purl.uniprot.org/core/author"Tezuka T."xsd:string
http://purl.uniprot.org/citations/12422060http://purl.uniprot.org/core/author"Higuchi H."xsd:string
http://purl.uniprot.org/citations/12422060http://purl.uniprot.org/core/author"Otani K."xsd:string
http://purl.uniprot.org/citations/12422060http://purl.uniprot.org/core/date"2002"xsd:gYear
http://purl.uniprot.org/citations/12422060http://purl.uniprot.org/core/name"Neuropsychobiology"xsd:string
http://purl.uniprot.org/citations/12422060http://purl.uniprot.org/core/pages"136-140"xsd:string
http://purl.uniprot.org/citations/12422060http://purl.uniprot.org/core/title"Association between -1438G/A promoter polymorphism in the 5-HT(2A) receptor gene and fluvoxamine response in Japanese patients with major depressive disorder."xsd:string
http://purl.uniprot.org/citations/12422060http://purl.uniprot.org/core/volume"46"xsd:string
http://purl.uniprot.org/citations/12422060http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/12422060
http://purl.uniprot.org/citations/12422060http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/12422060
http://purl.uniprot.org/uniprot/#_B2R7Y7-mappedCitation-12422060http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/12422060